COMMUNIQUÉS West-GlobeNewswire

Correction: Nuvectis Pharma Announces Participation at Upcoming Investor Conferences
09/02/2024
Fort Lee, NJ, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines [...]
Intelligent Bio Solutions Inc. Reports Fiscal Second Quarter and Six-Month Financial Results and Operational Highlights
09/02/2024
- Year-over-year revenue increased 114% for the fiscal second quarter and 337% for the six-months ending December 31, 2023 - - Expanded into New Zealand market and increased market share in existing regions - NEW YORK, [...]
PharmAla and Red Light Holland to Collaborate on Medical Psilocybin Development
09/02/2024
PharmAla will consult on GMP Drug Product and Regulatory Development for Red Light Holland VANCOUVER, British Columbia, Feb. 09, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ”) (CSE: MDMA) (OTC: [...]
MaxCyte to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 and Participate in Upcoming Investor Conferences
09/02/2024
ROCKVILLE, Md., Feb. 09, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and [...]
OneMedNet Sees Real World Data Growth in Women’s Health
09/02/2024
MINNEAPOLIS, Feb. 09, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade imaging Real World Data (“RWD”), today announced a growth [...]
Human Acellular Vessel™ (HAV™) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma
09/02/2024
– BLA submission supported by results from Phase 2/3 clinical trial and outcomes of real-world use of the HAV under a Humanitarian Aid Program to treat wartime trauma injuries in Ukraine – – The HAV had higher rates of [...]
Nuvectis Pharma Announces Participation at Upcoming Investor Conferences
09/02/2024
Fort Lee, NJ, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines [...]
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
09/02/2024
SOLANA BEACH, Calif., Feb. 09, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI [...]
Coloplast Finance B.V. - Interim Financial Report, Q1 2023/24
09/02/2024
Q1 2023/24 Interim financial results, Q1 2023/24 1 October 2023 - 31 December 2023 Coloplast delivered a solid Q1 with 8% organic growth and an EBIT margin 1) of 28%. Reported revenue in DKK grew 8% with 4%-points [...]
Inteleos Announces 2024 Board of Directors
09/02/2024
Board Brings Extensive Experience Across Healthcare To Support Inteleos’ Mission ROCKVILLE, Md., Feb. 09, 2024 (GLOBE NEWSWIRE) -- Inteleos, a non-profit global healthcare certification organization, today announced its [...]
OKYO Pharma Receives FDA Approval of IND for OK-101 in Neuropathic Corneal Pain
09/02/2024
OK-101 is the first IND clearance granted by FDA for a drug to begin clinical studies specifically to treat patients suffering with neuropathic corneal pain (NCP), a major unmet medical need The initial trial of OK-101 [...]
Vistin Pharma ASA: Invitation to Q4 2023 conference call
09/02/2024
Oslo, Norway, 9 February 2024 Vistin Pharma ASA will release its fourth quarter and preliminary 2023 results on Friday 16 th of February 2024. Vistin Pharma will host a conference call for all shareholders and [...]
Invitation to an extraordinary shareholders’ meeting of Novozymes A/S
09/02/2024
An extraordinary shareholders’ meeting of Novozymes A/S will be held on Monday March 4, 2024 at 4:00 pm CET at Boege Alle 10-12, 2970 Hoersholm, Denmark. Attachments 2024_09_EGM_Invitation Notice convening the [...]
Invitation to presentation of Mendus’ year-end report for 2023
09/02/2024
Mendus AB (“Mendus” publ; IMMU.ST), will publish its year-end report for 2023 on Wednesday 14 February 2024 at 08:00 CET. The company will hold a conference call and an online presentation on the same day at 10:00 CET. [...]
Coloplast launches Peristeen® Light for people with bowel disorders
09/02/2024
The new transanal irrigation device is designed to help people facing defecation issues or stool leakage. It is estimated that 10-15% of the world’s population are affected by chronic constipation 1 and that 6% struggle [...]
Coloplast A/S - Interim Financial Report, Q1 2023/24
09/02/2024
Q1 2023/24 Interim financial results, Q1 2023/24 1 October 2023 - 31 December 2023 Coloplast delivered a solid Q1 with 8% organic growth and an EBIT margin 1) of 28%. Reported revenue in DKK grew 8% with 4%-points [...]
KBC Securities Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 10.00 Per Share
09/02/2024
EINDHOVEN, the Netherlands, Feb. 09, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and independence in people [...]
IBA acquires Radcal Corporation to expand Medical Imaging Quality Assurance offering and strengthen US presence
09/02/2024
Highly complementary acquisition continues IBA’s expansion strategy to lead the Radiotherapy, Medical Imaging Dosimetry and Quality Assurance markets globally Louvain-la-Neuve, Belgium, February 9, 2024 – IBA (Ion Beam [...]
IBA acquiert Radcal Corporation afin d’élargir son offre d'assurance qualité en imagerie médicale et renforcer sa présence aux États-Unis.
09/02/2024
Acquisition complémentaire en vue de poursuivre la stratégie d'expansion d’IBA pour devenir le leader mondial du marché de l’assurance qualité en radiothérapie et en imagerie médicale. Louvain-la-Neuve, Belgique, le 9 [...]

Pages